Macquarie Group LTD Cardiovascular Systems Inc Transaction History

Macquarie Group LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$12.93 - $17.17 $13,770 - $18,286	-1,065 Reduced 52.05%	981 $28,000
Q3 2021 Nov 12, 2021	SELL	$32.83 - $43.0 $2 Million - $2.62 Million	-61,011 Reduced 96.76%	2,046 $67,000
Q1 2021 May 14, 2021	BUY	$37.29 - $47.19 $576,950 - $730,123	15,472 Added 32.51%	63,057 $2.42 Million
Q4 2020 Feb 16, 2021	SELL	$34.3 - $44.09 $359,498 - $462,107	-10,481 Reduced 18.05%	47,585 $2.08 Million
Q3 2020 Nov 13, 2020	SELL	$27.86 - $39.35 $57,391 - $81,061	-2,060 Reduced 3.43%	58,066 $2.29 Million
Q2 2020 Aug 11, 2020	BUY	$30.3 - $42.55 $679,932 - $954,821	22,440 Added 59.54%	60,126 $1.9 Million
Q1 2020 May 15, 2020	BUY	$30.0 - $54.18 $1.13 Million - $2.04 Million	37,686 New	37,686 $1.33 Million
Q4 2018 Feb 15, 2019	SELL	$25.26 - $38.43 $2,526 - $3,843	-100 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$33.27 - $39.25 $3,327 - $3,925	100 New	100 $4,000

35.5K

Ticker CSII
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 41,905,900
Description
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.